Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-087496

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mark K Bennett
Officer — SR. VP, RESEARCH
Period of report
Dec 29, 2015
Accepted (ET)
Dec 31, 2015 · 3:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 29, 2015M1,217$0.48A1,217D
Common StockDec 29, 2015M1,612$0.48A2,829D
Common StockDec 29, 2015M2,835$0.96A5,664D
Common StockDec 29, 2015M4,749$2.64A10,413D
Common StockF1holding———52,374IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$0.48Dec 29, 2015M1,217D—Dec 13, 2021Common Stock1,2170D
Stock Option (Right to Buy)F3$0.48Dec 29, 2015M1,612D—Jun 12, 2022Common Stock1,612807D
Stock Option (Right to Buy)F4$0.96Dec 29, 2015M2,835D—May 22, 2023Common Stock2,8358,034D
Stock Option (Right to Buy)F5$2.64Dec 29, 2015M4,749D—Dec 16, 2023Common Stock4,74918,998D

Explanation of responses